ArticleFrontiers in pharmacology2021

Novel Pan-Pim Kinase Inhibitors With Imidazopyridazine and Thiazolidinedione Structure Exert Potent Antitumor Activities.

Yuichi Sawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.